tirzepatide for alcohol use disorder GLP-1 medications get at the heart of addiction: study – WashU Medicine Semaglutide and tirzepatide decrease cravings

Gastroenterology Hepatology and Digestive Endoscopy suggests that 70 percent of people who frequently take anthraquinone laxatives will develop melanosis coli, often within just a few months of use

For clinical trials and research, the seven-day half-life affects study design

Researchers are further studying its potential for supporting fat loss and chronic weight management in overweight and obese individuals, as well as its anti-inflammatory, cardioprotective, and hepatoprotective effects

We believe that if even a single patient feels the need to turn to potentially unsafe and unapproved knockoff alternatives, that's one too many." The move comes amid mounting calls from patients and lawmakers alike including President Donald Trump for more affordable GLP-1 treatments